The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early-stage solid tumors. It is necessary that ctDNA test results are linked to clinical outcomes in order to demon...
We've found 3 total result s for "Carcinoma Ovarian Epithelial".
This phase I/Ib trial is to find out the best dose, possible benefits and/or side effects of BET bromodomain inhibitor ZEN-3694 (ZEN003694) when given in combination with nivolumab with or without ipilimumab in treating patients with solid tumors. ZEN003694 may stop ...
Age: 18 years - 66+
Gender: All
This phase II/III trial studies how well pegylated liposomal doxorubicin hydrochloride with atezolizumab and/or bevacizumab work in treating patients with ovarian, fallopian tube, or primary peritoneal cancer that has come back (recurrent). Chemotherapy drugs, such ...
- Carcinoma
- Adenocarcinoma
- Ovarian Neoplasms
- Carcinoma, Ovarian Epithelial
- Fallopian Tube Neoplasms
- Cystadenocarcinoma, Serous
- Carcinoma, Endometrioid
- Adenocarcinoma, Clear Cell
Age: 18 years - 66+
Gender: Female